Effect of 1-(phenyl)-N'-(4-methoxybenzylidene)-9H-pyrido[3,4-b] indole-3-carbohydrazide on in vitro poliovirus replication

Acta Pharmaceutica

Volumn 65, Issue 1, 2015, Pages 75-81

  Santos, Patricia Regina ^a   Formagio, Anelise S Nazari ^a   Filho, Benedito Prado Dias ^a   Nakamura, Celso Vataru ^a   Sarragiotto, Maria Helena ^a   Ueda Nakamura, Tania ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

1 (phenyl) N' (4 methoxybenzylidene) 9H pyrido 3,4 b indole 3 carbohydrazide; antiviral activity; b carboline; poliovirus

Indexed keywords

1 (PHENYL) N' (4 METHOXYBENZYLIDENE) 9H PYRIDO[3,4 B]INDOLE 3 CARBOHYDRAZIDE; ALKALOID; ANTIVIRUS AGENT; UNCLASSIFIED DRUG; 1-(PHENYL)-N'-(4-METHOXYBENZYLIDENE)-9H-PYRIDO(3,4-B)INDOLE-3-CARBOHYDRAZIDE; HYDRAZINE DERIVATIVE; INDOLE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG EXPOSURE; DRUG MECHANISM; ENTEROVIRUS INFECTION; HOST CELL; IN VITRO STUDY; NONHUMAN; PLAQUE FORMING CELL; POLIOMYELITIS VIRUS; PROPHYLAXIS; VERO CELL LINE; VIROGENESIS; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; VIRAL PLAQUE ASSAY;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; HYDRAZINES; INDOLES; POLIOVIRUS; VERO CELLS; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

EID: 84924871525     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.1515/acph-2015-0004     Document Type: Article

References (15)

1. J. L. Melnick, Current status of poliovirus infections, Clin. Microbiol. Rev. 9 (1996) 293-300.
2. B. Blondel, G. Duncan, T. Couderc, F. Delpeyroux, N. Pavio and F. Colbère-Garapin, Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells, J. Neurol. Virol. 4 (1998) 1-26; DOI: 10.3109/13550289809113478.
3. S. Muller, E. Wimmer and J. Cello, Poliovirus and poliomyelitis: A tale of guts, brain and an accidental event, Virus Res. 111 (2005) 157-193; DOI: 10.1016/j.virusres.2005.04.008.
4. WHO. Poliomyelitis, May 2014; http://www.who.int/mediacentre/factsheets/fs114/en/; last access date August 26, 2014
5. R. A. Tripp, Addressing the re-emergence of poliovirus, J. Antivir. Antiretrovir. 6 (2014) xxxiv-xxxv; DOI: 10.4172/jaa.1000e116.
6. Committee on Development of a Polio Antiviral and its Potential Role in Global Poliomyelitis Eradication, Exploring the Role of Antiviral Drugs in the Eradication of Polio: Workshop Report. The National Academy Press, Washington 2006.
7. B. Thys, L. Schoe, S. Muyldermans, U. Wernery, G. Hassanzadeh-Ghassabeh and B. Rombaut, In vitro antiviral activity of single domain antibody fragments against poliovirus, Antiviral Res. 87 (2010) 257-264; DOI: 10.1016/j.antiviral.2010.05.012.
8. M. S. Colle, J. Neyts and J. F. Modlin. A case for developing drugs against polio, Antiviral Res. 79 (2008) 179-187; DOI: 10.1016/j.antiviral.2008.04.002.
9. E. De Clercq, Highlights in antiviral drug research: antivirals at the horizon, Med. Res. Rev. (2012) 1215-1248; DOI: 10.1002/med.21256.
10. J. G. Tang, Y. H. Wang, R. R. Wang, Z. J. Dong, L. M. Yang, Y. T. Zheng and J. K. Liu, Synthesis of analogues of flazin, in particular, flazinamide, as promising anti-HIV agents, Chem. Biodivers. 5 (2008) 447-460; DOI: 10.1002/cbdv.200890044.
11. J. H. V. Maarseveen, H. W. Cheeren, E. D. Clerq, J. Balzarini and C. G. Kruse, Antiviral and tumor cell antiproliferative SAR studies on tetracyclic eudistomins-II, Bioorg. Med. Chem. 5 (1997) 955-970; DOI: 10.1016/S0968-0896(97)00034-5.
12. J. F. Miller, E. M. Turner, R. G. Sherrill, K. Gudmundsson, A. Spaltenstein, P. Sethna, K. W. Brown, R. Harvey, K. R. Romines and P. Golden, Substituted tetrahydro-b-carbolines as potential agents for the treatment of human papillomavirus infection, Bioorg. Med. Chem. Le. 20 (2010) 256-259; DOI: 10.1016/j.bmcl.2009.10.123.
13. A. S. N. Formagio, P. R. Santos, K. Zanoli, T. Ueda-Nakamura, L. T. Düsman Tonin, C. V. Nakamura and M. H. Sarragioo, Synthesis and antiviral activity of b-carboline derivatives bearing a substituted carbohydrazide at C-3 against poliovirus and herpes simplex virus (HSV-1), Eur. J. Med. Chem. 44 (2009) 4695-4701; DOI: 10.1016/j.ejmech.2009.07.005.
14. I. Camargo Filho, D. A. G. Cortez, T. Ueda-Nakamura, C. V. Nakamura and B. P. Dias Filho, Antiviral activity and mode of action of a peptide isolated from Sorghum bicolor, Phytomedicine 15 (2008) 202-208; DOI: 10.1016/j.phymed.2007.07.059.
15. P. Skehan, R. Storeng, A. Scudeiro Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/83.13.1107.